Hikma Pharmaceuticals has partnered with Ergomed in order for the latter to manage clinical trials involving Hikma treatments.

Signed in September 2011, the agreement will see Ergomed conduct the first clinical trials of Hikma’s key oncology products in Jordanian hospitals, which could potentially expand into the MENA region. In return, Ergomed will receive access to Hikma’s insight into the regional pharmaceutical sector.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Hikma CEO Said Darwazah heralded the partnership, saying: "Our decision to work with Ergomed comes from a strong commitment to continuous medical advancement through the use of clinical trials, especially in the field of oncology."

Ergomed CEO Miroslav Reljanovic echoed Darwazah’s sentiments before confirming that Ergomed is currently developing a full-service MENA business, which is to be managed from its head office, located in Dubai.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now